Legionella Infection 

  • Author: Mobeen H Rathore, MD, CPE, FAAP, FIDSA; Chief Editor: Russell W Steele, MD   more...
 
Updated: Oct 25, 2011
 

Background

Legionnaires disease (LD) was recognized in 1976 after an outbreak of pneumonia at an American Legion convention in Philadelphia. Soon after, the etiologic agent was identified as a fastidious gram-negative bacillus and named Legionella pneumophila. Although several other species of the genus Legionella were subsequently identified, L pneumophila is the most frequent cause of human legionellosis and a relatively common cause of community-acquired and nosocomial pneumonia in adults. In children, L pneumophila is also an important, although relatively uncommon, cause of pneumonia.

Legionellosis refers to 2 distinct clinical syndromes: Legionnaires disease, which most often manifests as severe pneumonia accompanied by multisystemic disease, and Pontiac fever, which is an acute, febrile, self-limited, viral-like illness.[1]

Next

Pathophysiology

Legionella organisms are aerobic, motile, and nutritionally fastidious pleomorphic gram-negative rods. The growth of the organisms depends on the presence of L-cysteine and iron in special media. The organism has been isolated in natural aquatic habitats (freshwater streams and lakes, water reservoirs) and artificial sources (cooling towers, potable water distribution systems). Freshwater amoebae appear to be the natural reservoir for the organisms.[2] Optimal growth temperature is 28-40°C; organisms are dormant below 20°C and are killed at temperatures above 60°C.

Although 64 Legionella serogroups have been identified among 42 species, L pneumophila causes most legionellosis. L pneumophila serogroup 1 alone is responsible for 70-90% of cases in adults. In a pediatric series, L pneumophila serogroup 1 accounted for only 48% of cases, serogroup 6 accounted for 33%, and the remaining cases involved other serotypes and species. Legionella micdadei and L dumoffii are the second and third most common species to cause Legionnaires disease in children, respectively.[3]

Transmission occurs by means of aerosolization or aspiration of water contaminated with Legionella organisms. Wounds may become infected after contact with contaminated water. The following systems are linked to transmission of Legionella organisms:

  • Cooling towers
  • Humidifiers
  • Respiratory therapy equipment
  • Whirlpool spas[4]
  • Evaporative condensers
  • Potable water distribution systems (eg, showers, faucets)[1, 5]

Most nosocomial infections and hospital outbreaks have been linked to contaminated hot water supply. However, contamination of cold-water supply has also been reported.[6] Nosocomial Legionnaires disease associated with water birth is reported in a few neonates, but the risk appears to be low.[7, 8] Person-to-person transmission has not been demonstrated.

Mucociliary action clears Legionella organisms are cleared from the upper respiratory tract. Any process that compromises mucociliary clearance (eg, smoking tobacco) increases risk of infection. Virulence varies between strains of L pneumophila. For example, some strains can adhere to the respiratory epithelial cells via pili, whereas strains with a mutated gene that encodes for the pili show reduced adherence in vitro.[9]

Organisms that reach the alveoli undergo phagocytosis by the alveolar macrophages but are not actively killed. Macrophages may actually support the growth of Legionella organisms. The bacteria multiply intracellularly until the cell ruptures. Liberated bacteria then infect other macrophages. Additional virulence factors include genes that potentiate infection of macrophages and inhibit phagosomal fusion, allowing intracellular growth.[10]

Cell-mediated immunity appears to be the primary host defense mechanism against Legionella infection. Activation of macrophages produces cytokines that regulate antimicrobial activity against Legionella organisms. Individuals with certain deficiencies in cell-mediated immunity are at increased risk for legionellosis.[3] Complicated cases have been reported in children treated with steroids.[11, 12]

The role of neutrophils in host defense against Legionella infection is unclear; neutropenia does not appear to predispose patients to legionellosis. Humoral immunity may play a secondary role.

Once infection is established, Legionella organisms cause an acute fibrinopurulent pneumonia with alveolitis and bronchiolitis. In addition to the lungs, Legionella organisms may infect the lymph nodes, brain, kidney, liver, spleen, bone marrow, and myocardium.[13]

Previous
Next

Epidemiology

Frequency

United States

An estimated 8000-18,000 cases of Legionnaires disease are reported in the United States each year. Most cases are not reported. More than 80% of cases are sporadic throughout the year, and the rest occur in outbreaks during the summer and early fall.

In adults, legionellosis causes 2-15% of all cases of community-acquired pneumonia (CAP) requiring hospitalization. Legionellosis is the second most frequent cause of severe pneumonia requiring ICU admission. Estimates for the proportion of nosocomial pneumonias caused by Legionella species widely vary, but the numbers probably represent an underestimation because most hospitals only test for serogroup 1.[14]

Serologic studies suggest that children are frequently exposed to Legionella species. However, this organism is not a common cause of acute respiratory disease in children.[15] The estimated frequency of Legionella pneumonia cases that require hospitalization is approximately 1-5%.[3, 16] The reported annual incidence of both CAPs and nosocomial pneumonias caused by Legionella species has increased. Most reported cases have involved neonates, children who are immunocompromised[3] (including those with prolonged courses of corticosteroids[11, 12] ), and children with underlying respiratory disease.[17]

International

Legionnaires disease is believed to have worldwide distribution and to cause 2-15% of all CAP cases requiring hospitalization.

Mortality/Morbidity

The mortality rate in patients with Legionnaires disease is 5-80%, depending on certain risk factors. The factors associated with high mortality rates include the following:

  • Age (especially those younger than 1 y and elderly patients)
  • Predisposing underlying conditions, such as chronic lung disease, immunodeficiency, malignancies, end-stage renal disease, and diabetes mellitus
  • Nosocomial acquisition
  • Delayed initiation of specific antimicrobial therapy

Sex

Males are more than twice as likely as females to develop Legionnaires disease.

Age

Middle-aged and older adults have a higher risk of developing Legionnaires disease than do young adults and children. Among children, more than one third of reported cases have occurred in infants younger than 1 year.

Previous
 
 
Contributor Information and Disclosures
Author

Mobeen H Rathore, MD, CPE, FAAP, FIDSA  Chief of Division of Pediatric Infectious Diseases/Immunology, Associate Chairman of Department of Pediatrics, University of Florida College of Medicine at Jacksonville; Hospital Epidemiologist and Section Chief of Infectious Disease and Immunology, Wolfson Children's Hospital; Director of University of Florida Center for HIV/AIDS Research, Education and Service (UF CARES)

Mobeen H Rathore, MD, CPE, FAAP, FIDSA is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, European Society for Paediatric Infectious Diseases, Florida Medical Association, Florida Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Society for Healthcare Epidemiology of America, Society for Pediatric Research, Southern Medical Association, and Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

Coauthor(s)

Ana Alvarez, MD  Associate Professor of Pediatrics, Pediatric Infectious Diseases Fellowship Director, University of Florida College of Medicine, Jacksonville

Ana Alvarez, MD is a member of the following medical societies: American Academy of Pediatrics, Florida Medical Association, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Glenn Fennelly, MD, MPH  Director, Division of Infectious Diseases, Lewis M Fraad Department of Pediatrics, Jacobi Medical Center; Clinical Associate Professor of Pediatrics, Albert Einstein College of Medicine

Glenn Fennelly, MD, MPH is a member of the following medical societies: Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Larry I Lutwick, MD  Professor of Medicine, State University of New York Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus

Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: Novartis Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References
  1. American Academy of Pediatrics. Legionella pneumophila infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:419-20.

  2. Gonzalez AG, Martin JM. Legionella pneumophila serogroup 1 pneumonia recurrence postbone marrow transplantation. Pediatr Infect Dis J. October 2007;26:961-963.

  3. Greenberg D, Chiou CC, Famigilleti R, Lee TC, Yu VL. Problem pathogens: paediatric legionellosis--implications for improved diagnosis. Lancet Infect Dis. Aug 2006;6(8):529-35. [Medline].

  4. Luttichau HR, Vinther C, Uldum SA, et al. An outbreak of Pontiac fever among children following use of a whirlpool. Clin Infect Dis. Jun 1998;26(6):1374-8. [Medline].

  5. Campins M, Ferrer A, Callis L, et al. Nosocomial Legionnaire's disease in a children's hospital. Pediatr Infect Dis J. Mar 2000;19(3):228-34. [Medline].

  6. Johansson PJ, Andersson K, Wiebe T, Schalen C, Bernander S. Nosocomial transmission of Legionella pneumophila to a child from a hospital's cold-water supply. Scand J Infect Dis. 2006;38(11-12):1023-7. [Medline].

  7. Franzin L, Scolfaro C, Cabodi D, et al. Legionella pneumophila pneumonia in a newborn after water birth: a new mode of transmission [case report]. Clin Infect Dis. Nov 1 2001;33(9):e103-4. [Medline].

  8. Thoni A, Zech N, Moroder L, Ploner F. [Water contamination and infection rate after water births]. Gynakol Geburtshilfliche Rundsch. 2007;47(1):33-8. [Medline].

  9. Stone BJ, Abu Kwaik Y. Expression of multiple pili by Legionella pneumophila: identification and characterization of a type IV pilin gene and its role in adherence to mammalian and protozoan cells. Infect Immun. Apr 1998;66(4):1768-75. [Medline].

  10. Rubin LG. Legionella species. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Philadelphia, PA: Churchill Livingstone; 2008:912-915.

  11. Myers C, Corbelli R, Schrenzel J, Gervaix A. Multiple pulmonary abscesses caused by Legionella pneumophila infection in an infant with croup. Pediatr Infect Dis J. Aug 2006;25(8):753-4. [Medline].

  12. Heine S, Fuchs A, von Muller L, Krenn T, Nemat S, Graf N. Legionellosis must be kept in mind in case of pneumonia with lung abscesses in children receiving therapeutic steroids. Infection. Oct 2011;39(5):481-4. [Medline].

  13. Monforte R, Marco F, Estruch R, Campo E. Multiple organ involvement by Legionella pneumophila in a fatal case of Legionnaires' disease. J Infect Dis. Apr 1989;159(4):809. [Medline].

  14. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.

  15. Scola BL, Maltezou H. Legionella and Q fever community acquired pneumonia in children. Paediatr Respir Rev. 2004;5 Suppl A:S171-7. [Medline].

  16. Wolf J, Daley AJ. Microbiological aspects of bacterial lower respiratory tract illness in children: atypical pathogens. Paediatr Respir Rev. Sep 2007;8(3):212-9, quiz 219-20. [Medline].

  17. Carlson NC, Kuskie MR, Dobyns EL, et al. Legionellosis in children: an expanding spectrum. Pediatr Infect Dis J. Feb 1990;9(2):133-7. [Medline].

  18. Sopena N, Sabria-Leal M, Pedro-Botet ML, et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest. May 1998;113(5):1195-200. [Medline].

  19. Qin X, Abe PM, Weissman SJ, Manning SC. Extrapulmonary legionella micdadei infection in a previously healthy child. Pediatr Infect Dis J. Dec 2002;21(12):1174-6. [Medline].

  20. Holmberg RE Jr, Pavia AT, Montgomery D, et al. Nosocomial Legionella pneumonia in the neonate. Pediatrics. Sep 1993;92(3):450-3. [Medline].

  21. Shachor-Meyouhas Y, Kassis I, Bamberger E, et al. Fatal hospital-acquired Legionella pneumonia in a neonate. Pediatr Infect Dis J. Mar 2010;29(3):280-1. [Medline].

  22. Tan MJ, Tan JS, Hamor RH, File TM Jr, Breiman RF. The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group. Chest. Feb 2000;117(2):398-403. [Medline].

  23. Hodina M, Hanquinet S, Cotting J, et al. Imaging of cavitary necrosis in complicated childhood pneumonia. Eur Radiol. Feb 2002;12(2):391-6. [Medline].

  24. Miller ML, Hayden R, Gaur A. Legionella bozemanii pulmonary abscess in a pediatric allogeneic stem cell transplant recipient. Pediatr Infect Dis J. Aug 2007;26(8):760-2. [Medline].

  25. Famiglietti RF, Bakerman PR, Saubolle MA, Rudinsky M. Cavitary legionellosis in two immunocompetent infants. Pediatrics. Jun 1997;99(6):899-903. [Medline].

  26. Gervaix A, Beghetti M, Rimensberger P, et al. Bullous emphysema after Legionella pneumonia in a two-year-old child. Pediatr Infect Dis J. Jan 2000;19(1):86-7. [Medline].

  27. Sasaki T, Matsumoto N, Nakao H, et al. An outbreak of Legionnaires' disease associated with a circulating bathwater system at a public bathhouse. I: a clinical analysis. J Infect Chemother. Apr 2008;14(2):117-22. [Medline].

  28. Stout JE, Sens K, Mietzner S, et al. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing. Int J Antimicrob Agents. Apr 2005;25(4):302-7. [Medline].

  29. Blazquez Garrido RM, Espinosa Parra FJ, Alemany Frances L, et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin Infect Dis. Mar 15 2005;40(6):800-6. [Medline].

  30. Watson AM, Boyce TG, Wylam ME. Legionella pneumonia: infection during immunosuppressive therapy for idiopathic pulmonary hemosiderosis. Pediatr Infect Dis J. Jan 2004;23(1):82-4. [Medline].

  31. Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventing health-care--associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. Mar 26 2004;53(RR-3):1-36. [Medline].

  32. Yu VL, Lee TC. Neonatal legionellosis: the tip of the iceberg for pediatric hospital-acquired pneumonia?. Pediatr Infect Dis J. Mar 2010;29(3):282-4. [Medline].

  33. Singh N, Stout JE, Yu VL. Prevention of Legionnaires' disease in transplant recipients: recommendations for a standardized approach. Transpl Infect Dis. Jun 2004;6(2):58-62. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.